Gestational Hypertension
80
21
28
31
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
3 terminated out of 80 trials
91.2%
+4.6% vs benchmark
14%
11 trials in Phase 3/4
29%
9 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 31 completed trials
Clinical Trials (80)
Pre-eclampsia and Future Cardiovascular Health: An Underused Opportunity to Improve Family Health
Role of L-citrulline in Prevention of Pregnancy Associated Hypertension
MH-Rx Study (Baby on Board: Check-in on You, Your Medication, & Your Blood Pressure)
Treatment With Aspirin After Preeclampsia: TAP Trial
Exploring the Effect of Discharge Education, Blood Pressure Cuffs, and Postpartum Bracelets to Improve Health Among Newly Diagnosed Gestational Hypertension and Preeclampsia Patients During the Postpartum Period.
Vagal Stimulation Therapy and Preeclampsia
Community Health Worker Support to Lower Blood Pressure After a Pregnancy With High Blood Pressure
Cardiovascular Protection After Preeclampsia With Enalapril
Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Pregnant Women With Hypertensive Disorders of Pregnancy
Preventing Obstetric Complications With Dietary Intervention
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
Brain Health in Midlife
Delivering HOPE (Helping Women Optimize Prenatal Equity)
Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
Optimal Blood Pressure Treatment Thresholds Postpartum
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women
CONNEQT Pulse Validation Study